Suzhou Abogen Biosciences Co. in China stated that the COVID-19 vaccine candidate using the messenger RNA (mRNA) technology targeting the Omicron variant has been approved for clinical trials in the United Arab Emirates.
With the announcement on Friday, Abogen joins Pfizer / BioNTech and Moderna in testing candidates that have been modified specifically against Omicron, a highly contagious variant with increased resistance to antibodies generated by current shots.
Mainland China has vaccinated over 88% of 1.4 billion people against COVID using non-mRNA syringes. It has not approved any foreign vaccines, although actual data have indicated that the two most widely used Chinese products, manufactured by Sinopharm and Sinovac, have less activity against COVID infection than mRNA shots from Pfizer / BioNTech and Moderna.
Outside the United Arab Emirates, Abogen was in contact with regulators in China and other countries about possible clinical trials for the Omicron-specific candidate, the statement said.
An MRNA candidate based on an older coronary virus strain without major mutations, developed by Abogen in collaboration with Walvax Biotechnology (300142.SZ) and a research institute supported by the Chinese military, is being tested in III. level study in China, Mexico and Indonesia.
Walvax is also partnering with startup company RNACure in Shanghai to develop a variant-targeted mRNA vaccine candidate with a different design than Abogen.
Two Omicron-specific vaccine candidates from Sinopharm and one from Sinovac, which contains inactivated or “killed” coronary heart disease virus, have been launched for clinical trials in Hong Kong and mainland China.
The United Arab Emirates regulator has approved clinical trials for Sinopharm’s third Omicron-specific candidate, as well as for two inactivated Omicron-specific candidates, the China National Biotec Group’s subsidiary Sinopharm said on Friday.
Chinese Omicron-specific mRNA COVID vaccine candidate tested in UAE – SABC News
Source link Chinese Omicron-specific mRNA COVID vaccine candidate tested in UAE – SABC News